BIOMAT Database Logo BIOMAT Database Logo

[Lithium carbonate in the treatment of diffuse toxic goiter]. 1982

L A Leshchinskiĭ, and V V Trusov, and L T Pimenov

UI MeSH Term Description Entries
D008094 Lithium An element in the alkali metals family. It has the atomic symbol Li, atomic number 3, and atomic weight [6.938; 6.997]. Salts of lithium are used in treating BIPOLAR DISORDER. Lithium-7,Lithium 7
D008297 Male Males
D005260 Female Females
D006111 Graves Disease A common form of hyperthyroidism with a diffuse hyperplastic GOITER. It is an autoimmune disorder that produces antibodies against the THYROID STIMULATING HORMONE RECEPTOR. These autoantibodies activate the TSH receptor, thereby stimulating the THYROID GLAND and hypersecretion of THYROID HORMONES. These autoantibodies can also affect the eyes (GRAVES OPHTHALMOPATHY) and the skin (Graves dermopathy). Basedow's Disease,Exophthalmic Goiter,Goiter, Exophthalmic,Graves' Disease,Basedow Disease,Hyperthyroidism, Autoimmune,Basedows Disease,Disease, Basedow,Disease, Basedow's,Disease, Graves,Disease, Graves',Exophthalmic Goiters,Goiters, Exophthalmic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D016651 Lithium Carbonate A lithium salt, classified as a mood-stabilizing agent. Lithium ion alters the metabolism of BIOGENIC MONOAMINES in the CENTRAL NERVOUS SYSTEM, and affects multiple neurotransmission systems. CP-15,467-61,Dilithium Carbonate,Eskalith,Lithane,Lithium Bicarbonate,Lithobid,Lithonate,Lithotabs,Micalith,NSC-16895,Priadel,Quilinorm-retard,Bicarbonate, Lithium,CP 15,467 61,CP15,46761,Carbonate, Dilithium,Carbonate, Lithium,NSC 16895,NSC16895,Quilinorm retard,Quilinormretard

Related Publications

L A Leshchinskiĭ, and V V Trusov, and L T Pimenov
[Lithium carbonate in the treatment of patients with diffuse toxic goiter].
June 1986, Vrachebnoe delo,
L A Leshchinskiĭ, and V V Trusov, and L T Pimenov
[Experience using lithium carbonate in the complex treatment of diffuse toxic goiter].
January 1985, Terapevticheskii arkhiv,
L A Leshchinskiĭ, and V V Trusov, and L T Pimenov
[Use of lithium carbonate in the therapy of diffuse toxic goiter].
January 1982, Problemy endokrinologii,
L A Leshchinskiĭ, and V V Trusov, and L T Pimenov
[The use of lithium carbonate in treating patients with diffuse toxic goiter].
October 1990, Klinicheskaia meditsina,
L A Leshchinskiĭ, and V V Trusov, and L T Pimenov
[Use of lithium carbonate in the combined surgical treatment of toxic goiter].
December 1982, Klinicheskaia khirurgiia,
L A Leshchinskiĭ, and V V Trusov, and L T Pimenov
[Impact of adjuvant therapy with lithium carbonate on the results of radioiodine treatment in patients with diffuse toxic goiter].
December 2007, Problemy endokrinologii,
L A Leshchinskiĭ, and V V Trusov, and L T Pimenov
[Calcitonin and parathyroid hormone secretion and calcium metabolism in patients with diffuse toxic goiter during treatment with lithium carbonate].
January 1984, Problemy endokrinologii,
L A Leshchinskiĭ, and V V Trusov, and L T Pimenov
Treatment of toxic diffuse goiter.
July 1969, Postgraduate medicine,
L A Leshchinskiĭ, and V V Trusov, and L T Pimenov
[Treatment of diffuse toxic goiter].
January 1986, Problemy endokrinologii,
L A Leshchinskiĭ, and V V Trusov, and L T Pimenov
[Surgical treatment of diffuse toxic goiter].
May 1979, Khirurgiia,
Copied contents to your clipboard!